Evommune, Inc. Common Stock (EVMN)

Financing Cash Flow

$274.22M

TTM · Period ending: · USD

EVMN logo

EVMN Financing Cash Flow

Latest reported$274.22M
EVMN Cash from Financing ($63.75M → $274.22M)
High-resolution chart · PNG

EVMN financing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
220,763,000
49,419,000
63,753,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.